| Literature DB >> 12223516 |
Tadaatsu Imaizumi1, Mika Kumagai, Naoko Sasaki, Hidekachi Kurotaki, Fumiaki Mori, Masako Seki, Nozomu Nishi, Koji Fujimoto, Kunikazu Tanji, Takeo Shibata, Wakako Tamo, Tomoh Matsumiya, Hidemi Yoshida, Xue-Fan Cui, Shingo Takanashi, Katsumi Hanada, Ken Okumura, Soroku Yagihashi, Koichi Wakabayashi, Takanori Nakamura, Mitsuomi Hirashima, Kei Satoh.
Abstract
Galectin-9 is a member of the galectin family and has been identified as an eosinophil chemoattractant produced by activated T lymphocytes. Vascular endothelial cells play an important role in the initial step of eosinophil recruitment and activation in immune and inflammatory responses. We have addressed the stimulation of galectin-9 expression in endothelial cells. Galectin-9 was detected in membrane and cytosolic fractions of human umbilical vein endothelial cells stimulated with interferon-gamma (IFN-gamma). IFN-gamma also enhanced the adhesion of human eosinophilic leukemia-1 cells to endothelial monolayers, and it was inhibited by the presence of lactose. Interleukin-4, which induces eotaxin expression, did not affect the expression of galectin-9. The in situ endothelium from patients with inflammatory diseases was found to express galectin-9. IFN-gamma-induced production of galectin-9 by endothelial cells may play an important role in immune responses by regulating interactions between the vascular wall and eosinophils.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12223516
Source DB: PubMed Journal: J Leukoc Biol ISSN: 0741-5400 Impact factor: 4.962